- SID Score
- 6.4/10
- Fair value
- $152.29
- Generated
- Oct 10, 2026
- Model
- claude-haiku-4-5-20251001
Morgan Stanley is trading at $190.02 with a market capitalization of $286.3 billion, currently valued at a P/E ratio of 17.5x. The stock presents a mixed investment profile with a SID Score of 6.4/10 and a fair value estimate of $152.29, suggesting the stock is overvalued by approximately 20%. While analyst consensus remains positive with a Buy rating and average price target of $181.00, the current market price exceeds this target, indicating potential near-term downside risk.
Morgan Stanley demonstrates modest fundamental strength across its factor grades, with Value, Growth, Profitability, and Dividends all rated at C-level, while Momentum lags at D. Recent earnings have shown mixed but generally positive results, with Q2 2026 EPS of $3.46 beating estimates of $2.81 and Q1 2026 EPS of $3.43 exceeding estimates of $3.04, though Q3 results remain pending. The company's minimal dividend yield of 0.02% suggests limited income generation for shareholders, and the absence of complete annual financial data limits comprehensive valuation assessment. The P/E ratio of 17.5x appears elevated relative to the fair value estimate, suggesting the market is pricing in optimistic growth assumptions.
The RSI(14) at 20.7 indicates the stock is in oversold territory, suggesting potential bounce-back opportunity or significant selling pressure in recent sessions. Morgan Stanley trades below its 50-day moving average of $207.33 but remains slightly above its 200-day moving average of $192.37, reflecting downward momentum over the intermediate term. The current price of $190.02 sits near the 200-day support level, which could serve as a critical technical floor; however, the bearish positioning below the 50-day MA suggests weakness in short-term momentum that contradicts the oversold RSI reading.
Analyst & Insider Sentiment
While analyst consensus recommends a Buy with an average price target of $181.00, this target is below the current trading price, implying limited upside potential at current levels. Insider activity has been decidedly negative, with major shareholder Mitsubishi UFJ Financial Group liquidating over 378 million shares across two separate transactions in July and September 2026, signaling reduced confidence from significant stakeholders. Additional insider selling by executives Mary L. Schapiro and Michael A. Pizzi in July further reinforces bearish sentiment among those with the most material information about company operations.
The substantial insider selling, particularly the $376.7 million share liquidation by Mitsubishi UFJ, represents a significant red flag regarding institutional confidence in the stock's valuation at current levels. The fair value estimate of $152.29 represents a 20% downside gap from current pricing, indicating considerable valuation risk if the market corrects toward fundamental values. The combination of oversold technical conditions (RSI 20.7), overvalued multiples relative to fair value, weak dividend support, and broad C-grade fundamental ratings across most factor categories creates a multifaceted risk profile that warrants cautious positioning.
Morgan Stanley presents a contrarian opportunity primarily suited to risk-tolerant investors who believe the insider selling represents capitulation rather than foreknowledge of deterioration. The stock's oversold technical condition (RSI 20.7) combined with support near the 200-day moving average ($192.37) may appeal to tactical traders seeking a reversal trade, though the 20% overvaluation gap and weak analyst consensus target suggest limited margin of safety for value investors. A more prudent approach would be to await either a decline toward the $152-$160 range for better entry pricing or confirmation that earnings growth will justify the current 17.5x multiple before establishing new positions.
